Renal vasculitis

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 9, 1996, Pages 69-74

  D'Amico, G ^a   Sinico, R A ^a   Ferrario, F ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

ANCA; Microscopic polyarteritis; Necrotizing crescentic GN; Renal vasculitis; Wegener's granulomatosis

Indexed keywords

CONFERENCE PAPER; KIDNEY BLOOD VESSEL; NECROTIZING ARTERITIS; POLYARTERITIS; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0030482955     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp9.69     Document Type: Conference Paper

References (47)

1. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international Consensus Conference. Arthritis Rheum 1994; 37: 187-192
2. Cameron JS. Vasculitis. In: Massry SG and Glassock RJ, eds. Textbook of Nephrology. Baltimore: Williams and Wilkins, 1995: 802-814
3. Falk RJ, Jennette JC. Renal vasculitis: microscopic polyarteritis, Wegener's granulomatosis and Churg-Strauss syndrome. In: Jacobson MR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. St Louis: Mosby, 1995: 178-186
4. Gaskin G, Pusey CD. Systemic Vasculitis. In: Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E, eds. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, 1992: 612-636
5. Pettersson EE, Sundelin B, Heigl Z. Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1995; 43:141-149
6. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 220: 467-483
7. Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125-136
8. Bindi P, Mougenot B, Mentre F et al. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 1993; 86: 55-68
9. Gans ROB, Kuizinga MC, Goldschmeding R et al. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 1993; 64: 182-188
10. Gordon M, Luqmam RA, Adu D et al. Relapses in patients with a systemic vasculitis. Q J Med 1993; 86: 779-789
11. Garrett PJ, Dewhurst AG, Morgan LS, Mason JC, Dathan JR. Renal disease associated with circulating antineutrophil cytoplasm activity. Q J Med 1992; 306: 731-749
12. Ferrario F (Gruppo Italiano di Immunopatologia Renale). Le vasculiti renali primitive. Giorn Ital Nefrol 1991; 8: 201-272
13. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982; 285: 606
14. van Der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies to neutrophils and monocytes: a new tool for dianosis and a marker of disease activity in Wegener's granulomatosis. Lancet 1985; ii: 425-429
15. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657
16. Cohen Tervaert JW, Goldschmeding K, Elema JD et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonepluitis. Kidney Int 1990; 37: 799-806
17. Jennette JC. Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis 1991; 18: 164-170
18. Mathieson PW, ed. Proceedings of the 5th International ANCA Workshop. Clin Exp Immunol 1993; 93: S1-S47
19. Sinico RA, Radice A, Pozzi C, Ferrario F, Arrigo G and the Italian Group of Renal Immunopathology. Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases. A prospective multicentre study. Nephrol Dial Transplant 1994; 9: 505-510
20. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15
21. Cohen Tervaert JW, Huitema MG, Hené RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711
22. Egner W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990; 82: 244-249
23. Kerr GR, Fleischer THA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-371
24. De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 1995; 25: 380-389
25. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumathol 1995; 13: 193-198
26. Davenport A, Lock RJ, Wellington T. Clinical significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. Am J Nephrol 1995; 15: 201-207
27. Ferrario F, Tadros MT, Napodano P, Sinico RA, Fellin G, D'Amico G. Critical reevaluation of 41 cases of 'idiopathic' crescentic glomerulonephritis. Clin Nephrol 1994; 41: 1-9
28. Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules and IL-1a expression in 15 cases of ANCA associated renal vasculitis. Am J Kidney Dis (in press)
29. Lan HY, Paterson DJ, Atkins RC. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 1991; 40: 425-433
30. Balow JE, Fauci AS. Vasculitic disease of the kidney: polyarteritis, Wegener's granulomatosis, necrotizing and crescentic granulomatosis, and other disorders. In: Schrier RW and Gottschalk CW, eds. Diseases of the Kidney. Boston, MA: Little Brown, 1993: 2095-2117
31. Wilkowski MJ, Velosa JA, Holley KE et al. Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney Int 1989; 36: 1133-1141
32. Serra A, Cameron JS, Turner DR et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984; 210: 181-207
33. Fuiano G, Cameron JS, Raftery M, BH Hartley, Williams DG, Ogg CS. Nephrol Dial Transplant 1988; 3: 383-391
34. Adu D, Howie AJ, Scott DGI, Bacon PA, McConigle RJS, Michael J. Polyarteritis and the kidney. Q J Med 1987; 62: 221-237
35. Pasquali S, Casanova S, Zucchelli A et al. Granulomatosi di Wegener: studio retrospettivo multicentrico di 43 pazienti con grave danno renale. Giorn Ital Nefrol 1991; 8: 205-213
36. Coppo R, Roccatello D, Fellin G et al. Poliarterite microscopica: andamento clinico e terapia. Giorn Ital Nefrol 1991; 8: 231-236
37. Altieri P, Pani A, Cabiddu GF et al. Glomerulonefrite necrotizzante idiopatica: follow-up e terapia. Giorn Ital Nefrol 1991; 8: 249-256
38. Rondeau E et al. Plasma exchange and immunosuppression for rapidly progressive glomerulonephritis: prognosis and complications. Nephrol Dial Transplant 1989; 4: 196-200
39. Huffman GS, Leavitt RY Fleisher THA, Minor JR, Fauci AS. Treatment of Wegener s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990; 89: 403-410
40. Falk JR, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990; 113: 656-663
41. Adu D, Pall A, Lugmani RA et al. Controlled trial of treatment of vasculitis. Clin Exp Immunol 1993; 93: 38-44
42. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992; 35: 1322-1329
43. Jennette JC, Falk RJ. Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. Lab Invest 1994; 70: 135-137
44. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40: 757-763
45. Jayne DRW, Black CM, Davies M, Fox C, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337: 1137-1139
46. Mathieson PW, Cobbold SP, Hale G et al. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 1990; 323: 250-254
47. Lockwood CM, Thiru S, Isaacs DJ, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993; 341: 1620-1622